Sandoz Group Ag reiterated earnings guidance for the full year 2024. For the year, The company reiterates guidance expecting net sales to grow mid-single digit in constant currencies versus prior year .
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
32.18 CHF | +1.67% | +0.37% | +18.92% |
07/06 | AbbVie's tight grip on Humira market raises concerns about biosimilars | RE |
22/05 | Sandoz: Marketing authorization for Wyost and Jubbonti in the EU | CF |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+18.92% | 1.54TCr | |
+19.64% | 4.33TCr | |
+21.25% | 2.22TCr | |
+20.14% | 1.45TCr | |
+53.19% | 1.27TCr | |
-0.05% | 678.76Cr | |
-11.11% | 670.81Cr | |
-8.87% | 572.55Cr | |
+14.68% | 549.79Cr | |
+6.91% | 478.4Cr |
- Stock Market
- Equities
- SDZ Stock
- News Sandoz Group AG
- Sandoz Group Ag Reiterates Earnings Guidance for the Full Year 2024